Advanced search
Publication Cover
Infectious Diseases Volume 52, 2020 - Issue 7
Submit an article Journal homepage
4,419
Views
75
CrossRef citations to date
0
Altmetric
Original Articles

Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study

Wei HouBeijing YouAn Hospital, Capital Medical University, Beijing, ChinaORCID Iconhttp://orcid.org/0000-0002-3497-4378
ORCID Icon,
Wei ZhangBeijing YouAn Hospital, Capital Medical University, Beijing, China
,
Ronghua JinBeijing YouAn Hospital, Capital Medical University, Beijing, China
,
Lianchun LiangBeijing YouAn Hospital, Capital Medical University, Beijing, China
,
Bin XuBeijing YouAn Hospital, Capital Medical University, Beijing, China
&
Zhongjie HuBeijing YouAn Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7313-5326
ORCID Icon
Pages 498-505 | Received 11 Apr 2020, Accepted 20 Apr 2020, Published online: 06 May 2020

References

  • Hui DS, E IA, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266.
  • Zhang N, Wang L, Deng X, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020;92(4):408–417.
  • WHO main website. https://www.who.int [accessed 11 April 2020].
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
  • Sun Y, Koh V, Marimuthu K, et al. Epidemiological and clinical predictors of COVID-19. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa322
  • Diagnosis and Treatment Protocol for Novel Coronavirus Infection-Induced Pneumonia version 7 (trial). National Health and Health Commission of China. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf [Accessed on 9 March 2020]
  • Sun P, Qie S, Liu Z, et al. Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection. J Med Virol. 2020;92(6):612–617.
  • Chen Y, Liu Q, Guo D. Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423.
  • Chan JCK, Tsui ELH, Wong V. The Hospital Authority SARS Collaborative Group. Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong. Respirology. 2007;12(4):531–542.
  • Hong KH, Choi JP, Hong SH, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2018;73(3):286–289.
  • Wang L, He W, Yu XM, et al. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020. DOI:10.1016/j.jinf.2020.03.019
  • Smits SL, de Lang A, van den Brand JMA, et al. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 2010;6(2):e1000756.
  • Sheng WH, Chiang BL, Chang SC, et al. Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome. J Formos Med Assoc. 2005;104(10):715–723.
  • Wang JT, Sheng WH, Fang CT, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10(5):818–824.
  • Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020. DOI:10.1097/CM9.0000000000000775
  • Xu Z, Shi L, Wang YJ, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422.
  • Huang CL, Wang YM, Li XW, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
  • Wang DW, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061.
  • Qian GQ, Chen XQ, Lv DF, et al. Duration of SARS-CoV-2 viral shedding during COVID-19 infection. Infect Dis. 2020. DOI:10.1080/23744235.2020.1748705
  • Yao TT, Qian JD, Zhu WY, et al. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus – a possible reference for coronavirus disease-19 treatment option. J Med Virol. 2020;92(6):556–563.
  • Zhou F, Yu T, Du RH, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.